YARW · Yarrow Bioscience, Inc. · Investor Relations
$20.00
+0.43 (+2.20%)
At close · Oct 29
Return incl. dividend (before tax)
Q3 2021 earnings call transcript
Market Cap
$52.15M
Shares
2.67M
Volume · Oct 29
228.61K
Avg daily vol (3M)
108.87K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-07-09 | VYNE Investor Relations Presentation | Presentation |
| 2025-03-20 | VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference | Conference |
| 2024-09-03 | VYNE Therapeutics to Participate in September Investor Conferences | Conference |
| 2024-02-21 | VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference | Conference |
| 2022-05-17 | KOL Event: Novel InhiBET BET Inhibitor Platform | Event |